Research explores intensive blood pressure control for patients with chronic kidney disease
The benefits of intensive blood pressure shown in the Systolic Blood Pressure Intervention Trial (SPRINT) also helps patients with chronic kidney disease, according to new research led by Kaiser Permanente and Stanford University. The study was published in January 2025 in JAMA Network Open. The SPRINT ...
Featured News
Study highlights the impact of electronic media use on young people
Young people who frequently used electronic media, such as computers, television, and social media, had less physical activity, more stress, and modest cognitive challenges. The study was published ...
New study sheds light on incidence of IgA nephropathy
A recent Kaiser Permanente study described the incidence of IgA nephropathy, an autoimmune kidney disease, nationally, as well as among people of different race and ethnicities. The study was published ...
RSV vaccine protects older adults against severe illness
A new study by Kaiser Permanente has shown that the ABRYSVO respiratory syncytial virus vaccine is very effective in reducing emergency room visits and hospital stays due to RSV among older adults. ...
Study finds air pollution may increase risk of preterm birth
December 2, 2024Exposure to a specific kind of air pollution, fine particulate matter, during pregnancy may significantly increase the risk of spontaneous preterm birth, which can be dangerous for both the mother and the baby, according to a Kaiser Permanente study published in JAMA Network Open. “Consistent with other study findings, this current study has demonstrated that there ...Read more...5 questions for … Dr. Javed Sheikh
November 22, 2024Javed Sheikh, MD, was recently named 2024 Physician Researcher of the Year by the Southern California Permanente Medical Group. Dr. Sheikh is the vice area research chair for the Los Angeles area on the Regional Research Committee. He is chief of the Department of Allergy and Immunology at the Kaiser Permanente Los Angeles Medical Center and ...Read more...Kaiser Permanente’s vaccine side-effect monitor bolsters safety
November 22, 2024After COVID-19 vaccines became available in December 2020, several smartphone-based reporting systems were developed to monitor vaccine side effects. They included V-safe from the Centers for Disease Control and Prevention. However, like most large surveillance systems, they had imperfections. Kaiser Permanente Southern California collaborated with the CDC and others to create a new system in April ...Read more...Five questions for … Dr. Kristi Reynolds
November 22, 2024Kristi Reynolds, PhD, MPH, is a chronic disease epidemiologist and the director of the Division of Epidemiologic Research for the Department of Research & Evaluation. Her research focuses on the prevention and treatment of hypertension, dyslipidemia, diabetes, and cardiovascular disease. She also studies medication adherence, drug safety, and cardiovascular quality of care and outcomes. Dr. Reynolds has more than ...Read more...No link between COVID-19 vaccines and cardiac-related death
November 22, 2024Research conducted at Kaiser Permanente has provided reassurance to the public and lawmakers by refuting claims that COVID-19 vaccines may increase the risk of cardiac-related death. “Our work reaffirms the previously established safety of COVID-19 vaccines,” said lead author Stanley Xu, PhD, of the Kaiser Permanente Southern California Department of Research & Evaluation. The study addressed concerns raised ...Read more...People with new-onset heart failure benefit from testing for coronary artery disease
November 22, 2024A new Kaiser Permanente study explores factors that might influence whether people with new-onset heart failure get tested for coronary artery disease. Published November 1, 2024, in JACC: Advances, it suggests that physician perceptions of the risks and benefits of testing, patient preferences, and socioeconomic challenges may all come into play. The study follows research published ...Read more...Younger adults respond to colorectal cancer screening outreach
October 24, 2024The updated national colorectal cancer screening guidelines that recommend screening begin at age 45 — rather than 50 — can benefit younger adults, a new Kaiser Permanente study found. The study was published October 22, 2024, in Annals of Internal Medicine. It included 267,732 Kaiser Permanente members in Northern California, Washington, and Colorado ages 45 to ...Read more...Opioid use among breast cancer survivors can increase risk of falls and fractures
October 16, 2024Breast cancer survivors commonly continue to use opioid pain killers after their cancer treatment is complete. A new Kaiser Permanente study shows that this can increase their risk of falls and bone fractures, lung problems, and cardiovascular conditions. The study was published in October 2024 in The Oncologist. A cancer epidemiologist partnered with a breast cancer survivor ...Read more...Five questions for … Dr. Heidi Brown
September 24, 2024Heidi Brown, MD, MAS, is a urogynecologist and a dissemination and implementation scientist who joined the Department of Research & Evaluation in August 2023. Her research focuses on improving access to effective solutions for pelvic floor disorders such as bladder and bowel incontinence and pelvic organ prolapse. She uses community engagement, user-centered design, and iterative ...Read more...No increased risk associated with flu vaccines given in closely spaced pregnancies
September 19, 2024Monitoring of about 45,000 pregnant people receiving flu vaccines in each of 2 successive pregnancies showed no increased risk of side effects or health issues, according to a Kaiser Permanente study published September 19, 2024, in JAMA Network Open. “Our study’s findings support recommendations to give flu vaccinations to pregnant persons even if they received a ...Read more...